Revolutionizing Cardio-Kidney-Metabolic Health: A Unified Approach
The healthcare landscape is witnessing a paradigm shift towards integrated care models, especially in the realm of cardio-kidney-metabolic (CKM) health. With alarming mortality rates and the interconnected nature of the heart, kidneys, liver, and pancreas, it's time to explore innovative solutions. Neerja Balachander, MBBS, PhD, at the American Heart Association Scientific Sessions 2025, emphasizes the need for collaboration among various medical professionals and organizations to combat the rising CKM disease prevalence.
The CKM disease landscape is complex, with shared mechanisms linking these organs. Endothelial dysfunction, inflammation, and fat deposition are key players in this interconnected web. Balachander highlights the importance of partnerships between industry, patient organizations, and professional societies, such as the Cardio-Kidney-Metabolic Alliance and the National Kidney Foundation. These collaborations aim to address the alarming fact that nearly 9 in 10 adults already have at least stage 1 CKM.
The Challenge: A Global Health Crisis
The numbers are staggering. 20 million patients die annually from cardio-kidney-metabolic conditions, and 65 million in the US alone suffer from at least one complication. The situation is dire, with 20 million patients having two or more of these conditions. This equates to the equivalent of 20 pandemics annually, a crisis that demands immediate attention.
The recent increase in cardiovascular mortality in the US, despite effective drugs, highlights the complexity of treatment. Patients may have multiple complications, making it crucial for general physicians and specialists to collaborate. Balachander advocates for a unified approach, where cardiologists, endocrinologists, nephrologists, and organizations like the AHA work together to develop implementation solutions.
Bridging the Gap: Collaborative Models
The key to success lies in collaborative models that bridge communication and care between cardiology, nephrology, and endocrinology. Balachander emphasizes that the body doesn't function in silos; organs are interconnected. For instance, a disease affecting the endothelium may start in the kidneys but eventually impact the heart. Similarly, fat deposition disorders can affect multiple organs, as inflammation spreads throughout the body.
Collaborative initiatives among industry, patient organizations, and professional societies are crucial. The Cardio-Kidney-Metabolic Alliance and the National Kidney Foundation are prime examples. These partnerships recognize the challenge of chronic diseases and aim to address them collectively. According to the AHA's CKM classification, the likelihood of having or developing CKM disease is almost 100%, making collective action imperative.
The Way Forward: Uniting for Change
The future of CKM health relies on continued collaboration and innovation. By working together, we can develop comprehensive solutions to manage and treat these interconnected conditions. Balachander's message is clear: it's time to unite our efforts and address this global health crisis head-on.
